Consolidated Statement Of Cash Flows

Oncolys BioPharma Inc. - Filing #7712866

Concept 2017-01-01 to
2017-06-30
As at
2017-06-30
As at
2016-12-31
As at
2016-06-30
2016-01-01 to
2016-06-30
As at
2015-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-515,048,000 JPY
-383,339,000 JPY
Interest and dividends received
427,000 JPY
1,713,000 JPY
Income taxes paid
-3,186,000 JPY
-2,249,000 JPY
Interest paid
-1,653,000 JPY
-1,856,000 JPY
Net cash provided by (used in) operating activities
-519,460,000 JPY
-385,732,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-965,000 JPY
-9,428,000 JPY
Net cash provided by (used in) investing activities
343,218,000 JPY
-121,120,000 JPY
Purchase of investment securities
-55,670,000 JPY
-112,620,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
955,637,000 JPY
30,837,000 JPY
Proceeds from long-term borrowings
100,000,000 JPY
JPY
Repayments of long-term borrowings
-11,536,000 JPY
-19,446,000 JPY
Net cash provided by (used in) financing activities
1,042,018,000 JPY
6,200,000 JPY
Effect of exchange rate change on cash and cash equivalents
-7,478,000 JPY
-12,375,000 JPY
Net increase (decrease) in cash and cash equivalents
858,298,000 JPY
-513,027,000 JPY
Cash and cash equivalents
2,277,291,000 JPY
1,418,993,000 JPY
1,547,225,000 JPY
2,060,252,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.